| Literature DB >> 35400145 |
Jun Kawakami1, Nobuyuki Yamamoto1, Eiji Itoi1, Heath Henninger2, Robert Tashjian2, Peter N Chalmers2.
Abstract
Background: Glenoid cartilage defects may contribute to anterior shoulder instability recurrence and progression to osteoarthritis, but their morphology remains unknown. Purpose/Hypothesis: The purpose was to determine the shape, size, and location of glenoid cartilage defects and the prevalence and risk factors for cartilage defects in the setting of anterior glenohumeral instability. It was hypothesized that glenoid cartilage defects would be common, would be associated with recurrence of dislocation, and would share similar morphology with glenoid osseous defects. Study Design: Cross-sectional study; Level of evidence, 3.Entities:
Keywords: anterior glenohumeral instability; cartilage defect; chondral defect
Year: 2022 PMID: 35400145 PMCID: PMC8984858 DOI: 10.1177/23259671221086615
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Segmentation of cartilage volume on MRI scans for shoulders with (A) no cartilage defects and (B) cartilage defects. The glenoid cortical bone was first semiautomatically segmented using built-in thresholding functions (blue area). The lower intensity than contrast and higher intensity than cortical bone area adjacent to the subchondral bone area was defined as the cartilage (green area). As the chondrolabral junction is difficult to determine on MRI scans, we defined the perimeter of the cartilage using the perimeter of the subchondral bone (yellow line). If the cartilage area ended within the perimeter of the subchondral bone, this was defined as a cartilage defect and separately segmented (red area). MRI, magnetic resonance imaging.
Figure 2.Measuring glenoid cartilage (left) and glenoid cartilage defect (right). Cartilage is shown in green; defect, in yellow. The following points were identified: glenoid superior pole (point A); glenoid inferior pole (point B); and glenoid center point (point O), which was defined as the midpoint between points A and B. From the superior and inferior points, the glenoid length was calculated (length of line AB). Glenoid width (length of line CD) was measured between points C (posterior) and D (anterior) as the widest distance orthogonal to line AB. The defect length was then measured from the intersection between the superior margin of the defect and the anterior rim of the glenoid cartilage (point E) to the intersection between the inferior margin of the defect and the anterior rim of the glenoid cartilage (point F). These same points were then used to determine the location of superior and inferior extent of the defect (angle EOF). The defect width was then measured midway between the superior and inferior points described above orthogonal to the length of the defect (line GH). The defect orientation was then measured as the line perpendicular to the length of the defect (line OI), relative to the line from the superior to the inferior glenoid poles (angle AOI).
Characteristics of Included Patients
| Variable | Value |
|---|---|
| Female sex | 27 (86/322) |
| Tobacco use | 13 (42/322) |
| Contact/collision athlete | 28 (89/322) |
| Recurrent dislocation | 74 (239/322) |
| No. of previous dislocations | |
| Subluxation(s) only | 9 (30/318) |
| 1 | 16 (52/318) |
| 2-5 | 57 (182/318) |
| >5 | 17 (54/318) |
| Age, y (n = 322) | 26.8 ± 10.3 (13-71) |
| BMI (n = 303) | 26.4 ± 5.6 (17-51) |
| Time from first event to surgery, mo (n = 297) | 40 ± 60 (0-480) |
Data are reported as percentages (n/total) or mean ± SD (range). BMI, body mass index.
Surgical Characteristics of Included Patients
| Variable | Value |
|---|---|
| Patient positioning | |
| Lateral decubitus | 85 (273/322) |
| Beach chair | 15 (49/322) |
| Concomitant superior labral repair | 9 (30/322) |
| Concomitant posterior labral repair | 17 (54/322) |
| Pan-labral repair | 3 (8/322) |
| No. of anchors | |
| <3 | 10 (30/315) |
| 3 | 32 (102/315) |
| 4 | 30 (95/315) |
| 5 | 17 (52/315) |
| >5 | 11 (36/315) |
| Other concomitant procedure | |
| Remplissage | 11 (35/322) |
| Rotator interval closure | 2 (5/322) |
| Biceps tenodesis | 5 (17/322) |
| Distal clavicle excision | 1 (2/322) |
| Subacromial decompression | 1 (3/322) |
| Rotator cuff repair | 3 (11/322) |
| HAGL repair | 3 (9/322) |
Data are reported as percentages (n/total). HAGL, humeral avulsion of the glenohumeral ligament.
Defect Characteristics and Measurement Reliability
| ICC (95% CI) | |||
|---|---|---|---|
| Variable | Mean ± SD | Interrater Reliability | Intrarater Reliability |
| Glenoid length, mm | 41.1 ± 3.6 | 0.986 (0.974-0.992) | 0.984 (0.970-0.991) |
| Glenoid width, mm | 27.7 ± 2.7 | 0.992 (0.985-0.995) | 0.988 (0.978-0.993) |
| Defect superior point, deg (clockface equivalent) | 65 ± 16 | 0.994 (0.990-0.997) | 0.956 (0.922-0.976) |
| Defect extent, deg (clockface equivalent) | 57 ± 21 | 0.945 (0.902-0.969) | 0.945 (0.902-0.969) |
| Defect inferior point, deg (clockface equivalent) | 122 ± 19 | 0.938 (0.890-0.965) | 0.942 (0.896-0.967) |
| Defect midpoint, deg (clockface equivalent) | 94 ± 14 | 0.949 (0.909-0.972) | 0.872 (0.779-0.928) |
| Defect orientation, deg (clockface equivalent) | 82 ± 8 | 0.998 (0.997-0.999) | 0.999 (0.997-0.999) |
| Defect length, mm | 14.7 ± 5.5 | 0.994 (0.988-0.997) | 0.989 (0.979-0.994) |
| Defect width, mm | 3.9 ± 1.7 | 0.995 (0.990-0.997) | 0.994 (0.988-0.996) |
| Defect surface area, % of glenoid cartilage surface area | 6.5 ± 3.5 | 0.992 (0.985-0.995) | 0.988 (0.978-0.993) |
ICC, intraclass correlation coefficient.
Figure 3.Flowchart of selection of defects for segmentation. 3D, 3-dimensional; Shlds, shoulders.
Figure 4.Schematic of the mean cartilage defect extent on the clockface. Grey area shows SDs.
Figure 5.A subset of patients displayed the cartilage defect subtype of an anterosuperior defect shown. This was thought to be an avulsion of the anteroinferior glenohumeral ligament complex from the glenoid.
Comparison Between Patients With Cartilage Defect Versus No Cartilage Defect
| Variable | Cartilage Defect | No Cartilage Defect |
|
|---|---|---|---|
| Female sex | 20 (24/121) | 31 (62/201) |
|
| Tobacco user | 15 (18/121) | 12 (24/201) | .449 |
| Contact/collision athlete | 30 (36/121) | 26 (53/201) | .511 |
| No. of dislocations | .553 | ||
| <2 | 25 (30/121) | 28 (56/201) | |
| 2-5 | 17 (21/121) | 15 (30/201) | |
| >5 | 58 (70/121) | 57 (115/201) | |
| Recurrent dislocations | 77 (93/212) | 73 (146/201) | .401 |
| Age, y | 27.2 ± 10.2 | 26.5 ± 10.3 | .390 |
| BMI | 26.6 ± 5.2 | 26.3 ± 5.8 | .364 |
| Time from dislocation to surgery, mo | 39.9 ± 58.2 | 40.4 ± 60.6 | .651 |
| Superior repair | 9 (11/121) | 10 (19/201) | .914 |
| Posterior repair | 23 (28/121) | 13 (26/201) |
|
| Remplissage | 12 (14/121) | 10 (21/201) | .754 |
| Biceps tenodesis | 6 (7/121) | 5 (10/201) | .753 |
| Rotator cuff repair | 4 (5/121) | 3 (6/201) | .583 |
| HAGL repair | 2 (2/121) | 4 (7/201) | .335 |
Data are reported as percentages (n/total) or mean ± SD. Bold values indicate statistically significant differences between groups (P < .05). BMI, body mass index; HAGL, humeral avulsion of the glenohumeral ligament.